Roth Capital Starts CV Sciences (CVSI) at Buy
Tweet Send to a Friend
Roth Capital analyst Scott Fortune initiates coverage on CV Sciences (OTC: CVSI) with a Buy rating and a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE